GTEX-139UC
|
61-70
|
Male
|
GTEX-139UC-1426 |
Liver
|
PAXgene |
1
|
2 pieces, moderte congestion
|
Acceptable
|
 |
GTEX-139UW
|
61-70
|
Male
|
GTEX-139UW-1026 |
Liver
|
PAXgene |
2
|
2 pieces; not congested; no fat
|
Acceptable
|
 |
GTEX-139YR
|
51-60
|
Male
|
GTEX-139YR-0226 |
Liver
|
PAXgene |
1
|
2 pieces; macrovesicular steatosis, Mallory hyaline, pericellular and perivenular fibrosis, and rare acute inflammation c/w alcohol use
|
Acceptable
|
 |
GTEX-13CF2
|
61-70
|
Male
|
GTEX-13CF2-0626 |
Liver
|
PAXgene |
1
|
2 pieces, mild congestion
|
Acceptable
|
 |
GTEX-13CIG
|
51-60
|
Male
|
GTEX-13CIG-1426 |
Liver
|
PAXgene |
2
|
2 pieces; severe macrovesicular steatosis; no cirrhosis
|
Acceptable
|
 |
GTEX-13CZV
|
61-70
|
Male
|
GTEX-13CZV-1426 |
Liver
|
PAXgene |
1
|
2 pieces; moderate central congestion with cord cell atrophy; no fat, no fobrosis
|
Acceptable
|
 |
GTEX-13FHO
|
61-70
|
Male
|
GTEX-13FHO-1126 |
Liver
|
PAXgene |
1
|
2 pieces; includes capsule (target is 1cm below capsule), cirrhosis with severe microvesicular and macrovesicuar steatosis, Mallory hylaine
|
Acceptable
|
 |
GTEX-13FHP
|
51-60
|
Male
|
GTEX-13FHP-1426 |
Liver
|
PAXgene |
1
|
2 pieces; moderate vascular congestion
|
Acceptable
|
 |
GTEX-13FLV
|
41-50
|
Male
|
GTEX-13FLV-0326 |
Liver
|
PAXgene |
1
|
2 pieces; includes portion of capsule (target is 1 cm below capsule), mild steatosis, passive congestion, focal portal chronic inflammation
|
Acceptable
|
 |
GTEX-13FLW
|
51-60
|
Male
|
GTEX-13FLW-0626 |
Liver
|
PAXgene |
2
|
2 pieces; chronic passive congestion
|
Acceptable
|
 |
GTEX-13FTW
|
41-50
|
Male
|
GTEX-13FTW-1126 |
Liver
|
PAXgene |
1
|
2 pieces; severe microvescicular and macrovesicular (predominant) steatosis, mild fibrosis
|
Acceptable
|
 |
GTEX-13FTY
|
41-50
|
Female
|
GTEX-13FTY-0826 |
Liver
|
PAXgene |
2
|
2 pieces; moderate steatosis, congestion
|
Acceptable
|
 |
GTEX-13FTZ
|
61-70
|
Male
|
GTEX-13FTZ-0726 |
Liver
|
PAXgene |
2
|
2 pieces; moderate macrovesicular steatosis with some fibrosis
|
Acceptable
|
 |
GTEX-13FXS
|
51-60
|
Male
|
GTEX-13FXS-1426 |
Liver
|
PAXgene |
1
|
2 pieces; severe steatosis, congestion
|
Acceptable
|
 |
GTEX-13G51
|
61-70
|
Male
|
GTEX-13G51-0626 |
Liver
|
PAXgene |
1
|
3 pieces; mild steatosis
|
Acceptable
|
 |
GTEX-13IVO
|
61-70
|
Male
|
GTEX-13IVO-1526 |
Liver
|
PAXgene |
2
|
2 pieces;10% macrovesicular steatosis; central congestion and degeneration
|
Acceptable
|
 |
GTEX-13JUV
|
41-50
|
Female
|
GTEX-13JUV-0726 |
Liver
|
PAXgene |
1
|
2 pieces; congestion
|
Acceptable
|
 |
GTEX-13JVG
|
61-70
|
Male
|
GTEX-13JVG-1526 |
Liver
|
PAXgene |
1
|
2 pieces; severe steatosis
|
Acceptable
|
 |
GTEX-13N11
|
41-50
|
Female
|
GTEX-13N11-0926 |
Liver
|
PAXgene |
0
|
2 pieces; includes capsule (target is 1cm below capsule), mild steatosis and some portal chronic inflammation
|
Acceptable
|
 |
GTEX-13N1W
|
61-70
|
Male
|
GTEX-13N1W-1326 |
Liver
|
PAXgene |
2
|
2 pieces; congestion and mild fatty change
|
Acceptable
|
 |
GTEX-13N2G
|
51-60
|
Male
|
GTEX-13N2G-0926 |
Liver
|
PAXgene |
1
|
2 pieces; congestion and accentuation of portal triads with fibrosis and mild lymphocytic infiltrate
|
Acceptable
|
 |
GTEX-13NYB
|
41-50
|
Male
|
GTEX-13NYB-1026 |
Liver
|
PAXgene |
1
|
2 pieces, diffuse macrovesicular steatosis involves >80% parenchyma
|
Acceptable
|
 |
GTEX-13NYC
|
61-70
|
Male
|
GTEX-13NYC-0526 |
Liver
|
PAXgene |
2
|
2 pieces; portal fibrosis, congestion
|
Acceptable
|
 |
GTEX-13NYS
|
61-70
|
Male
|
GTEX-13NYS-1226 |
Liver
|
PAXgene |
1
|
2 pieces; nodular cirrhosis, alcoholic hyalin (Mallory bodies) with 50% macrosteatosis
|
Acceptable
|
 |
GTEX-13NZ8
|
61-70
|
Female
|
GTEX-13NZ8-1826 |
Liver
|
PAXgene |
2
|
2 pieces; 10% macrovesicular steatosis
|
Acceptable
|
 |